Article
Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patients.
Cancer biomarkers : section A of Disease markers - 1 Jan 2010
Kumar Kalyana, Vamsy Mohana, Jamil Kaiser
Abstract excerpt
Our study supports the Drug-Gene Interaction principle, where patients experience adverse drug reactions (ADRs) due to genetic predisposition or due to single nucleotide polymorphisms (SNPs) in drug metabolizing genes. The target enzyme for 5- Fluorouracil is thymidylate synthase (TYMS) this enzyme is also involved in folate metabolism. We determined the frequencies of polymorphisms in drug metabolizing enzyme...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
